Menu

08/04/2026

A study on platelet-rich plasma, among the most cited in 2024 in BioMed Research International

The scientific article “Current Challenges in the Development of Platelet-Rich Plasma-Based Therapies,” published in the journal BioMed Research International, has been recognized as one of the journal’s 10 most-cited papers of 2024, according to data from Clarivate Analytics.

What is the study about?

The paper analyzes the collection of platelet-rich plasma (PRP), a biological therapy derived from the patient’s own blood.

PRP contains platelets, which play a role in the body’s natural repair processes, and is used in various areas of medicine, particularly in the treatment of muscle, tendon, and joint injuries.

What does this study contribute?

The article reviews current advances in this type of therapy and highlights that:

• Research has focused primarily on improving methods for obtaining PRP.
• However, further research is needed on how to optimize its biological composition to increase its efficacy.
• There are new lines of research aimed at developing more precise and personalized therapies.

Why is this important for patients?

This type of research directly contributes to:

• Improving the quality and efficacy of regenerative treatments.
• Moving toward safer therapies tailored to each patient.
• Driving innovation in regenerative medicine based on scientific evidence.

A study involving MiKS Hospital

This study involved the medical and research team at MiKS Hospital, in collaboration with various internationally renowned research groups, including the Microfluidics Cluster at the University of the Basque Country (EHU), the BIOMICs microfluidics research group at the EHU, the Microanalytical Systems and Materials for Lab-on-a-Chip (AMMa-LOAC) group at the University of the Basque Country (EHU), as well as the Basque Foundation for Science (IKERBASQUE). This multidisciplinary collaboration integrates clinical experience and advanced knowledge in biomedical engineering, microfluidics, and lab-on-a-chip technologies, with the aim of advancing the development of more effective regenerative therapies that are better tailored to patients’ needs.

Scientific Recognition

The fact that this article ranks among the most cited of the year reflects its international significance and its impact on the scientific community.

At MiKS Hospital, we wish to highlight this joint achievement, which is the result of coordinated efforts between the clinical team, researchers, and collaborating centers, and which reinforces our commitment to research and the continuous improvement of patient care.